Drug ID:Drug38
Drug Name:Picosulfuric Acid
CID:5243
DrugBank ID:DB09268
Modality:Small Molecule
Groups:NULL
US Approved:YES
Other Approved:YES
Identifier: NCT02009202
Molecular Formula:C18H15NO8S2
Molecular Weight:437.4 g/mol
Isomeric SMILES:C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)O)C3=CC=C(C=C3)OS(=O)(=O)O
Synonyms:Picosulfuric acid; Picosulfate; 10040-34-3; Picosulphate; UNII-95D580798S; PICOSULFATE [VANDF]; 95D580798S; DTXSID70143251; Phenol, 4,4'-(2-pyridinylmethylene)bis-, 1,1'-bis(hydrogen sulfate); {4-[(pyridin-2-yl)[4-(sulfooxy)phenyl]methyl]phenyl}oxidanesulfonic acid
Phase 0: 0
Phase 1: 5
Phase 2: 9
Phase 3: 16
Phase 4: 29
Description:NULL

Molecular Structure

2D Molecular Structure

Knowledge Graph

dtIDCIDCompound NameGene IDGene NameSpeciesPubMed IDsAction
No data available

  • No data available

Phase Distribution
Phase Description
  • Phase 0: Exploratory trials to assess drug behavior in humans
  • Phase 1: Safety trials to determine safe dosage range
  • Phase 2: Efficacy trials to evaluate therapeutic effects
  • Phase 3: Large-scale trials to confirm efficacy and safety
  • Phase 4: Post-marketing surveillance for long-term safety and efficacy

Trial IDTitlePhaseStatusSponsorIndicationsInterventions
NCT03593252 Bowel Preparation in Elective Pediatric Colorectal Surgery NA UNKNOWN McMaster University Colostomy|Hirschsprung Disease - Pull Through|Nec… DRUG: Senna|DRUG: Sodium Picosulfate, Magnesium O… Details
NCT03581149 Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients PHASE4 UNKNOWN American University of Beirut Medical Center Ulcerative Colitis DRUG: Sodium Picosulfate/Magnesium Citrate Laxati… Details
JPRN-UMIN000046015 A prospective, controlled, randomized, assessor-blind, comparative study of a new oral bowel cleanser (Sodium Picosulfate/Magnesium Citrate) versus existing oral bowel cleanser (Magnesium Citrate) in pediatric colonoscopy preparation. - A prospective, con NULL Not Recruiting Saitama children's Medical Center Division of Gastroenterology and Hepatology Inflammatory bowel disease, Functional gastrointe… PICOPREP MAGCOROL Powder Details
ChiCTR2200056969 Efficacy, tolerability and safety of Sodium picosulphate/magnesium citrate versus 3-L polyethylene glycol for bowel preparation for patients with Inflammatory Bowel Disease NULL Recruiting Shenzhen Hospital of Southern Medical University Bowel preparation Experimental group:intake sodium picosulfate/magn… Details
NCT05726097 Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure PHASE3 COMPLETED Region Skane Colon Cancer|Inflammatory Bowel Diseases|Gastroin… DRUG: polyethylene glycol|DRUG: sodium phosphate|… Details
NCT02009202 Preparation Prior to Colonoscopy in Children NA COMPLETED Skane University Hospital Inflammatory Bowel Diseases DRUG: polyethylene glycol|DRUG: picosulphate Details
NCT07138898 Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty PHASE2 NOT_YET_RECRUITING NYU Langone Health Rheumatic Disease DRUG: Methotrexate|DRUG: Sulfasalazine|DRUG: Hydr… Details
NCT05016024 Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome. NA COMPLETED Aboca Spa Societa' Agricola Irritable Bowel Syndrome DEVICE: Colilen IBS|OTHER: Placebo Details
NCT02227602 Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease NA COMPLETED Texas A&M University Intestinal Diseases|Ulcerative Colitis|Crohn Dise… DRUG: Mango polyphenolics Details
NCT01570348 Crohn's Allogeneic Transplant Study PHASE2 TERMINATED Fred Hutchinson Cancer Center Crohn Disease PROCEDURE: Allogeneic Bone Marrow Transplantation… Details
NCT05990764 Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS) NA UNKNOWN AronPharma Sp. z o. o. IBS - Irritable Bowel Syndrome DIETARY_SUPPLEMENT: Probiotic, Prebiotic, Polyphe… Details
NCT05687474 Baby Detect : Genomic Newborn Screening NULL COMPLETED Centre Hospitalier Universitaire de Liege Congenital Adrenal Hyperplasia|Familial Hyperinsu… None Details
NCT05668013 A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease PHASE2 ACTIVE_NOT_RECRUITING Teva Branded Pharmaceutical Products R&D LLC Crohn Disease|Colitis, Ulcerative DRUG: TEV-48574 Dose Regimen A|DRUG: TEV-48574 Do… Details
NCT07168434 Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome PHASE3 RECRUITING Biocodex IBS (Irritable Bowel Syndrome)|IBS-D (Diarrhea-pr… DRUG: Saccharomyces Boulardii 250 MG|DRUG: Placeb… Details
NCT05588843 Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis PHASE2 ACTIVE_NOT_RECRUITING Sanofi Colitis Ulcerative DRUG: SAR443122|DRUG: Placebo Details
NCT05575505 Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis. PHASE2 RECRUITING Tanta University Inflammatory Bowel Diseases DRUG: Pentoxifylline 400 MG Details
NCT05558761 Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis PHASE2 COMPLETED Tanta University Inflammatory Bowel Diseases DRUG: Pentoxifylline 400 MG Details
NCT05549323 A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis PHASE1 TERMINATED Pfizer Ulcerative Colitis DRUG: PF-07054894|DRUG: Placebo Details
NCT05535946 ABTECT - Maintenance PHASE3 ACTIVE_NOT_RECRUITING Abivax S.A. Ulcerative Colitis DRUG: ABX464|DRUG: Placebo Details
NCT05509777 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease PHASE3 RECRUITING Eli Lilly and Company Crohn's Disease DRUG: Mirikizumab Details

Disease IDDisease NameDefinitionCategoryRelated DrugsMechanism
No data available

Strategy IDTherapeutic StrategySynonymsRelated DrugsMechanism
S04 T-cell homing and retention T-cell trafficking vedolizumab; anti-MAdCAM1 antibodies ; etrolizumab Inhibition of the interaction between α4β7 integrins on T c… Details
S06 Anti-fibrosis fibrosis; tissue remodelling GS-5745; STNM01 Tissue remodelling and destruction in patients with IBD is … Details
S07 Blockade of cytokine Cytokine signalling apremilast; roflumilast; filgotinib; tofacitinib; ABT494; ABT-874; ustekinumab; isankizumab; LY-2525623; AMG139; MEDI2079; guselkumab Various T-cell subsets, their differentiation pathways and … Details

No related literature

You can run management commands to establish drug-literature associations